List view / Grid view
20 January 2014 | By OPTIMA Pharma
Stephan Reuter is the new CEO of OPTIMA pharma GmbH in Mornshausen, a worldwide known manufacturer of high quality innovative freeze-drying systems for the pharmaceutical and biotechnology industries...
16 January 2014 | By Bristol-Myers Squibb
Three-year commitment provides significant support for new generation of diabetes researchers...
16 January 2014 | By Johnson & Johnson
Janssen is seeking approval of rivaroxaban at a proposed dose of 2.5 mg twice daily (BID) for a 90 day treatment duration...
15 January 2014 | By Sanofi
Goal is to identify novel active compounds to accelerate the discovery and development of new antibiotics...
15 January 2014 | By Amgen
Collaboration brings unique expertise together focus is to translate IBD gene and biology findings into potential new treatment options for patients...
14 January 2014 | By kdm Communications
Join Tecan on booth #405 at this year’s SLAS Conference and Exhibition in San Diego, California, to discover the latest developments in automated liquid handling...
14 January 2014 | By Daiichi Sankyo Co., Ltd
Ranbaxy received the form 483 with certain observations as a result of the recent US FDA inspection at its API plant at Toansa, Punjab, India...
14 January 2014 | By AstraZeneca
At the conference, Pascal Soriot will provide an update on the company’s development pipeline and outline its strategic priorities for 2014...
13 January 2014 | By Merck
“We’re taking significant and decisive action to make Merck a more competitive company, better positioned to drive innovation and growth...”
13 January 2014 | By GlaxoSmithKline
This transfer of rights represents the termination of the collaboration agreement between GSK and Prosensa executed in 2009....
13 January 2014 | By Teva Pharmaceuticals Industries Ltd
Multiple genes associated with potential therapeutic effects expressed differently: Gene expression analysis provides insight into variability...
13 January 2014 | By Sanofi
Genzyme will have significant rights to Alnylam’s portfolio of clinical and pre-clinical stage drug candidates...
13 January 2014 | By AstraZeneca
AstraZeneca and Bristol-Myers Squibb Company announced the FDA approved FARXIGA™ (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus...
12 January 2014 | By Novartis
Novartis announced that Hervé Hoppenot, President of Novartis Oncology, will leave Novartis with immediate effect...
The British Generic Manufacturers Association (BGMA) has appointed Thomas Broeer, managing director of Kent Pharmaceuticals, as its new chair for the next two years.
